[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/main/docs/Benef/index.md) >> Individual ID:PBN__Benef_65 

# __Vaccine design and analysis__

## Articles mentionning this Benefit

* [CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_13.md)

## Stakeholders benefitting from this Benefit

* [researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [scientists](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_46.md)

## Description of Benefits pertaining to Beneficiaries

* [Private investors can benefit indirectly from the improved vaccine design and analysis, potentially leading to the development of effective vaccines, attracting investment and commercial interest.](https://github.com/mm80843/T3.5/blob/main/docs/BenefReturn/PBN__BenefReturn_65.md)

## Name of the Benefit

CIDO facilitates the annotation and modeling of vaccine candidates, aiding in the design and analysis of potential vaccines against coronaviruses.

